Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Veritas Capital, Elliott to buy Athenahealth for $5.7 billion

Published 11/12/2018, 03:41 PM
Updated 11/12/2018, 03:41 PM
© Reuters. FILE PHOTO -  Immelt delivers speech during the opening of a new tower of the Global Operations Center in San Pedro Garza Garcia

(Reuters) - Private equity firm Veritas Capital and hedge fund Elliott Management are buying Athenahealth Inc (O:ATHN) for about $5.7 billion, the U.S. healthcare software maker said on Monday.

The all-cash deal values Athenahealth at $135 per share, representing a premium of 12.2 percent to the stock's closing price on Friday.

Reuters reported on Sunday that Athenahealth had agreed to a takeover.

Athenahealth had been under pressure from Elliott to sell itself since the hedge fund acquired a stake in the company last year. In May Elliott made an unsolicited offer of $160 per share to buy Athenahealth.

The Watertown, Massachusetts-based company, whose cloud-based software is used to track revenue from patients, physicians and hospitals, has cut jobs and overhauled its management over the past year as part of a restructuring effort.

Former General Electric (N:GE) Chief Executive Officer Jeff Immelt currently serves as its chairman.

Once the deal is complete, Athenahealth will merge with Virence Health, the former GE Healthcare unit that Veritas acquired earlier this year, the companies said in a joint statement.

A deal for Athenahealth represents the largest deal to date for Elliott's private equity arm, Evergreen.

In June Athenahealth's founder and CEO Jonathan Bush, a nephew of former U.S. President George H.W. Bush, stepped down following a newspaper report alleging he had assaulted his former wife 14 years earlier.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.